Sunitinib Induced Cytopenia in Metastatic RCC

Clinical Medical Reviews and Case Reports
doi 10.23937/2378-3656/1410208
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ClinMed International Library

Related search

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favourable/Intermediate Risk: Multicentre Randomised Trial CROSS-J-RCC

Clinical Genitourinary Cancer
OncologyUrology
2020English

Antimicrobial-Induced Cytopenia and Bone Marrow Hypocellularity in Patients With Cirrhosis

Bone Marrow Research
ImmunologyCell BiologyHematology
2018English

Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

A Case of Metastatic Adamantinoma That Responded Well to Sunitinib

Case Reports in Oncological Medicine
Oncology
2016English

Lower Limbs Erosions Induced by Sunitinib

Acta Dermato-Venereologica
DermatologyMedicine
2011English

HLA Class II Haplotypes Predict Favorable Outcomes for Patients With Metastatic RCC

Der Urologe
Urology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy